glp 1 insulin combo Glucagon-like peptide (GLP-1) Trial suggests GLP-1 combo therapy
Description
A 24-week multicenter, randomized, double-blind, placebo-controlled clinical study conducted by Apovian (53) found that EX combined with lifestyle adjustment could significantly reduce the weight of patients, all of which were 6.16 0.54 kg
However, the beneficial effects of SGLT-2 such as weight loss, renal protection, and metabolic benefit make SGLT-2 a potential therapeutic option post-transplantation among patients with metabolic syndrome, obesity, and kidney dysfunction
How GLP-1 Medications Work and Why Food Choices Still Matter GLP-1 medications work by influencing several key systems in the body: They slow gastric emptying, meaning food stays in the stomach longer They increase feelings of fullness after smaller meals They reduce hunger signals in the brain They improve insulin sensitivity and blood sugar control While these effects reduce calorie intake, they also change how the body tolerates food
Biosocial variation in treatment response to GLP-1s: implications for clinical care and health policy
